Advanced search
Publication Cover
Leukemia & Lymphoma Volume 18, 1995 - Issue 1-2
Submit an article Journal homepage
49
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

Samer Suki Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, P. O. Box 117, Keyser, West Virginia
,
Forrest Swan Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
,
Susan Tucker Department of Biomathematics, University of Texas M. D. Anderson Cancer, Center, Houston Texas
,
Herbert A. Fritsche Division of Laboratory Medicine, University of Texas M. D. Anderson Cancer, Center Houston, Texas
,
John R. Redman Wyeth-Ayerst Laboratories, Radnor, Pennsylvania
,
Maria Alma Rodriguez Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
,
Peter McLaughlin Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
,
Jorge Romaguera Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
,
Fredrick B. Hagemeister Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
,
William S. Velasquez Department of Hematology, University of St. Louis School of Medicine, St. Louis, Missouri, USA
,
Andreas H. Sarris Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
,
Anas Younes Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
&
Fernando Cabanillas Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
 show all
Pages 87-92 | Received 12 Aug 1994, Published online: 01 Jul 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Kazuhito Suzuki, Yasuhito Terui, Masahiro Yokoyama, Kyoko Ueda, Noriko Nishimura, Yuko Mishima, Sakura Sakajiri, Naoko Tsuyama, Kengo Takeuchi & Kiyohiko Hatake. (2013) Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone. Leukemia & Lymphoma 54:11, pages 2412-2417.
Read now
Taner Korkmaz, Selcuk Seber, Kerem Okutur, Gul Basaran, Fulden Yumuk, Faysal Dane, Tunc Ones, Ozge Polat, Ozlem Cakir Madenci, Gokhan Demir & N. Serdar Turhal. (2013) Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer. Biomarkers 18:1, pages 88-94.
Read now
Mary J. Ninan, Punit D. Wadhwa & Pankaj Gupta. (2011) Prognostication of diffuse large B-cell lymphoma in the rituximab era. Leukemia & Lymphoma 52:3, pages 360-373.
Read now
Ondrej Topolcan & Lubos Holubec$suffix/text()$suffix/text(). (2008) The role of thymidine kinase in cancer diseases. Expert Opinion on Medical Diagnostics 2:2, pages 129-141.
Read now
S. Aref, M. Fouda, E. El-Dosoky, A. Menessy, M. Mabed, M. Saleeb & K. Zalata. (2003) Lymphoproliferative Disease. Hematology 8:3, pages 183-190.
Read now

Articles from other publishers (9)

Gordon J. Ruan, Sangeetha Gandhi, Jithma P. Abeykoon, Susan Schram, Thomas M. Habermann, Benjamin J. Sandefur & Thomas E. Witzig. (2021) Elevated Serum Lactate in Patients With Lymphoma: It Is Not Always Infection. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5:2, pages 423-430.
Crossref
D. H. Thamm, D. A. Kamstock, C. R. Sharp, S. I. Johnson, E. Mazzaferro, L. V. Herold, S. M. Barnes, K. Winkler & K. A. Selting. (2011) Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma * . Veterinary and Comparative Oncology 10:4, pages 292-302.
Crossref
Zhi-Ming Li, Ying-Jie Zhu, Jian Sun, Yi Xia, Jia-Jia Huang, Ben-Yan Zou, Tong-Yu Lin, Hui-Qiang Huang & Wen-Qi Jiang. (2012) Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma. Annals of Hematology 91:8, pages 1265-1270.
Crossref
Ji‐Won Kim, Hyun Jung Lee, Hyeon Gyu Yi, Byung‐Su Kim, Soo‐Mee Bang, Jin Seok Kim, Inho Kim, Sung‐Soo Yoon, Jong Seok Lee, Chul Soo Kim, Seonyang Park & Byoung Kook Kim. (2012) Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non‐Hodgkin lymphoma. American Journal of Hematology 87:5, pages 479-483.
Crossref
Zhu-Lin Pan, Xing-Ying Ji, Yan-Min Shi, Ji Zhou, Ellen He & Sven Skog. (2010) Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients. Journal of Cancer Research and Clinical Oncology 136:8, pages 1193-1199.
Crossref
Wei Xu, Xin Cao, Kou-Rong Miao, Chun Qiao, Yu-Jie Wu, Qiong Liu, Lei Fan & Jian-Yong Li. (2009) Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. International Journal of Hematology 90:2, pages 205-211.
Crossref
Henrik von Euler, Roland Einarsson, Ulf Olsson, Anne‐Sofie Lagerstedt & Staffan Eriksson. (2008) Serum Thymidine Kinase Activity in Dogs with Malignant Lymphoma: A Potent Marker for Prognosis and Monitoring the Disease. Journal of Veterinary Internal Medicine 18:5, pages 696-702.
Crossref
F. Di Raimondo, R. Giustolisi, S. Lerner, E. Cacciola, S. O’Brien, H. Kantarjian & M.J. Keating. (2001) Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine. Annals of Oncology 12:5, pages 621-625.
Crossref
Q. He, L. Zou, P.A. Zhang, J.X. Lui, S. Skog & T. Fornander. (2018) The Clinical Significance of Thymidine Kinase 1 Measurement in Serum of Breast Cancer Patients Using Anti-TK1 Antibody. The International Journal of Biological Markers 15:2, pages 139-146.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.